Related Experiment Videos

Histochemically demonstrable protein tyrosine phosphatase in human breast and colorectal cancer: large decrease in

S Partanen1

  • 1Department of Pathology, Jorvi Hospital, Espoo, Finland.

Anticancer Research
|March 1, 1996
PubMed

Insights

Protein tyrosine phosphatases (PTPs) may not act as tumor suppressors in breast cancer, as PTP activity increased in most breast cancers. However, PTPs likely function as tumor suppressors in colorectal cancer, with activity dropping significantly in cancerous tissues.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Protein tyrosine kinases (PTKs) and growth factor receptors are key in cell signaling.
  • Protein tyrosine phosphatases (PTPs) regulate phosphotyrosine protein levels.
  • PTP inhibition causes cellular proliferation, suggesting a tumor suppressor role.

Purpose of the Study:

  • Investigate the tumor suppressor activity of PTPs in human breast and colorectal tissues.
  • Analyze PTP activity and phosphotyrosine protein content in normal and cancerous tissues.
  • Determine the relationship between PTP activity and cancer development.

Main Methods:

  • Histochemical techniques were used to demonstrate PTP activity and phosphotyrosine protein content.
  • Analysis was performed on normal human breast tissue and breast cancer samples.
  • Analysis was performed on normal human colorectal mucosa and colorectal cancer samples.

Main Results:

  • In breast tissue, PTP activity was low in normal tissue but increased in most cancers, with no inverse correlation to phosphotyrosine protein.
  • In colorectal mucosa, PTP activity was high in normal tissue but drastically decreased (to 14%) in colorectal cancers.
  • Alterations in PTP genes further support a role in colorectal cancer development.

Conclusions:

  • PTPs may not function as tumor suppressors in human breast tissue and cancer.
  • A significant decrease in PTP activity in colorectal cancer suggests a tumor suppressor role in this tissue.
  • Reduced PTP activity could be a factor in colorectal cancer's neoplastic proliferation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K